Many Laboratory Corporation of America Holdings(LH) Stock Research Financial Advisors from Investment Banking firms have advised their client and investors on the stock. Laboratory Corp. of America Holdings was Downgraded by Robert W. Baird on Feb 6, 2017 to Neutral, Price Target of the shares are set at $138.Laboratory Corp. of America Holdings was Initiated by Deutsche Bank on Jan 18, 2017 to Buy, Price Target of the shares are set at $170.
Company has reported several Insider transactions to the SEC, on Aug 11, 2016, Lisa J Uthgenannt (Chief Human Resources Officer) sold 1,177 shares at 140.00 per share price.On Aug 8, 2016, Glenn A Eisenberg (Chief Financial Officer, EVP) sold 8,000 shares at 140.38 per share price.On Aug 8, 2016, Robert E Jr Mittelstaedt (director) sold 992 shares at 140.15 per share price.
Laboratory Corp. of America Holdings Last issued its quarterly earnings results on Oct 26, 2016. The company reported $2.25 EPS for the quarter, missing the analyst consensus estimate by $ -0.04. Analyst had a consensus of $2.29. The company had revenue of $2372.70 million for the quarter, compared to analysts expectations of $2375.79 million. The companys revenue was up 4.5% compared to the same quarter last year. During the same quarter in the previous year, the company posted $2.07 EPS.
Laboratory Corporation of America Holdings (NYSE:LH) has received a short term rating of hold from experts at Zacks with a rank of 3. The stock has been rated an average of 1.59 by 16 Brokerage Firm. 10 Wall Street Firms have rated the stock as a strong buys. 2 stock experts have also suggested a buy rating. 4 Brokerage Firms have advised hold.
Laboratory Corporation of America Holdings (NYSE:LH) should head towards $149.3 per share according to 15 Analysts in consensus. However, if the road gets shaky, the stock may fall short to $132 per share. The higher price estimate target is at $170 according to the Analysts.
Laboratory Corporation of America Holdings (NYSE:LH) rose 0.7% or 0.95 points on Tuesday and made its way into the gainers of the day. After trading began at $135.19 the stock was seen hitting $136.21 as a peak level and $134.135 as the lowest level. The stock ended up at $135.88. The daily volume was measured at 748,755 shares. The 52-week high of the share price is $141.32 and the 52-week low is $102.42. The company has a market cap of $13,996 million.
Laboratory Corporation of America Holdings, is one of the largest independent clinical laboratory companys in the United States. Through a national network of laboratories, the company offers different clinical laboratory tests which are used by the medical profession in routine testing, patient diagnosis, and in the monitoring and treatment of disease.